July 23, 2025 The Critical Path Institute Podcast: eCOA Conversations on Digital Health Technologies This newest podcast episode from Critical Path Institute’s® (C-Path) Electronic Clinical Outcome Assessment (eCOA) Consortium..
July 22, 2025 Join Global Leaders in Shaping the Future of Drug Development at C-Path’s 2025 Global Impact Conference Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...
July 16, 2025 Characterizing Tau Accumulation and Amyloid-tau Interactions in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial and Their Implications for Advancing Drug Development
July 16, 2025 Impact of non-linear SUVR transformations on the statistical power of tau-PET longitudinal studies
July 16, 2025 Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...
July 16, 2025 C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....
July 15, 2025 Preventing, Delaying Type 1 Diabetes Critical Path Institute, which formed the T1D Consortium in 2017, is working to accelerate the process to new therapies...
July 14, 2025 Principles of good practice for concept definition in the context of translation and linguistic validation of clinical outcome assessments (COAs) Translation teams conducting translation and cultural adaptation find it paramount to properly describe concepts of items...
July 9, 2025 C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..